20th Biosimilar Medicines Conference

  • 2022

Description

The 20th Biosimilar Medicines Conference covers topics such as:

  • Biosimilars: the European Commission industrial policy strategy and "Tajani initiative" follow-up
  • Biological and biosimilar medicines market: current status and future outlook
  • Biosimilars uptake: best practice sharing by key EU member states
  • Biosimilars evolving landscape: insight into market access
  • Real World Evidence sharing
  • Debate on GfK study findings: a multi-stakeholder approach in support of the biosimilar medicines market sustainability
  • Biosimilars naming and labelling regime: the European experience
  • The science of extrapolation of indications, explained by EU regulators
  • Biosimilar medicines approvals and scientific guidelines latest developments: the EMA overview
  • WHO Biological Qualifier Scheme: status of the proposal
  • Biosimilars: news from the US/FDA
  • Biosimilars global development: the role of WHO and National Drug Regulatory Authorities
  • The biosimilarity concept: bringing it closer to patients, healthcare professionals and medical societies

The 20th Biosimilar Medicines Conference brings together International Regulators, leading EU and Experienced EU Companies.

Past Events

Important

Please, check "Biosimilar Medicines Conference" official website for possible changes, before making any traveling arrangements

Event Categories

Health & Medicine: Pharma

Other Events with Similar Categories

Other Events with Similar Location or Organizer

Featured Conferences & Exhibitions